Pharmacogenetic Phenotyping and Genotyping
- 1 January 1994
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 26 (1), 59-70
- https://doi.org/10.2165/00003088-199426010-00005
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.1993
- Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoinClinical Pharmacology & Therapeutics, 1992
- Clinical implications of variable antiarrhythmic drug metabolismPharmacogenetics, 1992
- Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisolClinical Pharmacology & Therapeutics, 1992
- Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypesPharmacogenetics, 1991
- N-acetyltransferase polymorphism: Comparison of phenotype and genotype in humansBiochemical Pharmacology, 1991
- Evolution of the P450 gene superfamily:: animal-plant ‘warfare’, molecular drive and human genetic differences in drug oxidationTrends in Genetics, 1990
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990
- Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.1989
- Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.Proceedings of the National Academy of Sciences of the United States of America, 1988